Quality CareFind out why Mayo Clinic is the right place for your health care. Make an appointment.
Meet the StaffFind a directory of doctors and departments at all Mayo Clinic campuses. Visit now.
Research and Clinical TrialsSee how Mayo Clinic research and clinical trials advance the science of medicine and improve patient care. Explore now.
Visit Our SchoolsEducators at Mayo Clinic train tomorrow’s leaders to deliver compassionate, high-value, safe patient care. Choose a degree.
Professional ServicesExplore Mayo Clinic’s many resources and see jobs available for medical professionals. Get updates.
Give to Mayo ClinicHelp set a new world standard in care for people everywhere. Give now.
The Tumor Angiogenesis and Vascular Biology Lab is studying a promising dopamine-based individualized therapy for patients with lung cancer.
Dr. Mukhopadhyay's lab analyzes how the GIPC protein affects tumor growth and metastasis to design new personalized therapies for patients with cancer.
The lab is developing strategies to target specific VEGF-independent pathways that allow renal cell tumors to evade anti-VEGF therapy.
The Tumor Angiogenesis and Vascular Biology Lab studies a region of the FIH enzyme responsible for FIH transcriptional activity in renal cancer.
The lab uses NRP1-deficient transgenic mouse lines and animal models to address the functional role of NRP1 in cardiovascular diseases.
The lab uses powerful tools to explore VEGF-mediated molecular mechanisms and their roles in vascular permeability and related diseases.
Mayo Clinic is a not-for-profit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.